Genomic Health to Market Epic Sciences’ AR-V7 Liquid Biopsy Test
NEW YORK (GenomeWeb) - Genomic Health and Epic Sciences today announced that they have signed an exclusive agreement under which Genomic Health will commercialize Epic Sciences' AR-V7 liquid biopsy test in the United States.
Read the entire story on GenomeWeb